1. HBW Insight
  2. >>Health
  3. >>Innovation & IP

OTC Marketing Awards 2023: What The Judges Said About The Leading Entries

 
• By Tom Gallen

The trophies have been presented at the OTC Marketing Awards 2023 - but what did the judging panel have to say about the winning and highly-commended entries?

OTC Marketing Award Winners 2023 • Source: Philippa Gedge

Consumer health companies and their agencies have been recognized for their achievements over the past year at the OTC Marketing Awards 2023.

A panel of 30 expert judges decided the winners across 14 categories with the trophies handed out at a ceremony...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Innovation & IP

GSCF: ‘No One Size Fits All’ Solution To Tricky Sustainable Blister Pack Challenge

 
• By David Ridley

A series of research papers recently published by the Global Self-Care Federation indicate that industry will need to be pragmatic about alternatives to PVC in medicine blister packs.

Maternal Nutrition, Contraceptive Innovation Among Gates Foundation’s Latest Research Goals

 
• By Malcolm Spicer

“Women’s health continues to be ignored, underfunded, and sidelined. Too many women still die from preventable causes or live in poor health. That must change,” says Bill Gates.

Over The Counter: Seizing The Healthy Aging Opportunity, With Prime Fifty’s Max Gowland

 
• By David Ridley

HBW Insight speaks to Prime Fifty founder and managing director Max Gowland about the science behind healthy aging and the opportunity for the consumer health industry.

German Switch Committee Supports OTC Melatonin And Acyclovir, Rejects Rupatadine

 
• By David Ridley

Germany’s Expert Committee for Prescription supports the Rx-to-OTC switches of melatonin and buccal acyclovir but rejects rupatadine.

More from Health

Maternal Nutrition, Contraceptive Innovation Among Gates Foundation’s Latest Research Goals

 
• By Malcolm Spicer

“Women’s health continues to be ignored, underfunded, and sidelined. Too many women still die from preventable causes or live in poor health. That must change,” says Bill Gates.

New US FDA Chief Counsel More Familiar With Trump World Than Food and Drug Law

 
• By Sarah Karlin-Smith

Sean Keveney is largely unknown in the FDA law space, but likely is familiar and connected to the White House given his work on Trump’s antisemitism taskforce.

People On The Move: Appointments At Enzymatica, Haleon, Futura

 
• By Tom Gallen

A round up of the latest moves in Europe's consumer health market: Enzymatica appoints CEO; Haleon hires DACH marketing chief; Futura confirms interim CEO.